GSK-Novartis global deal not to impact India business: GSKCH (9)

The Hindu 2014.04.22 15:40
PTI GlaxoSmithKline Consumer Healthcare on Tuesday said the multi-billion dollar global deal between parent GlaxoSmithKline Plc. and Swiss drug major Novartis won't affect its business in India. The two companies agreed to form a joint venture by combining Novartis' over-the-counter division with GSK's consumer business to create a business with $10 billion in annual sales.
VACCINE, ONCOLOGY, DEAL, ELI, MILESTONE, DIVESTITURE, Jimenez, Heilprin, USA, Швейцария